Showing results (11-20 of 173) with videos related to
Sort By:
Pageof 18
Recenti Progressi in Medicina|April 11, 2019
[The new oncological mutational model. What changes in regulatory processes and in the reimbursement of cancer target therapies.]Antonella Pedrini, Nello MartiniRecenti Progressi in Medicina|December 20, 2021
[The tools for the governance of mutational oncology and agnostic drugs: from place in therapy to place in pathway.]Nello Martini, Carlo PiccinniRecenti Progressi in Medicina|March 25, 2024
[The domino effect of drug distribution channels on the management of chronicity.]Carlo Piccinni, Nello MartiniBMJ Open|December 13, 2019
Anticancer drug prices and clinical outcomes: a cross-sectional study in ItalyFrancesco Trotta, Flavia Mayer, Francesco Barone-Adesi, et al.Recenti Progressi in Medicina|April 25, 2018
[Biosimilars: Italian Medicines Agency takes position.]Antonio AddisRecenti Progressi in Medicina|April 23, 2020
[CoViD-19: we knew everything but we didn't understand anything.]Antonio AddisRecenti Progressi in Medicina|February 24, 2021
[From drug evaluation to that of a path: the challenges for regulatory authorities.]Antonio AddisRecenti Progressi in Medicina|April 23, 2020
[CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]Nello Martini, Carlo Piccinni, Antonella Pedrini, et al.Recenti Progressi in Medicina|June 10, 2024
[Update of the Pdta Net Observatory of the ReS Foundation with all regional Care Pathways approved until 2023.]Irene Dell'Anno, Silvia Calabria, Nello Martini, et al.Pageof 18